Literature DB >> 19216624

Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses.

Ponraj Prabakaran1, Zhongyu Zhu, Xiaodong Xiao, Arya Biragyn, Antony S Dimitrov, Christopher C Broder, Dimiter S Dimitrov.   

Abstract

BACKGROUND: Recently, several potently neutralizing fully human monoclonal antibodies (hmAbs) targeting the severe acute respiratory syndrome-associated coronavirus (SARS CoV) S glycoprotein, and the G glycoprotein of the paramyxoviruses Hendra virus (HeV) and Nipah virus (NiV) have been discovered [corrected].
OBJECTIVE: To examine, compare and contrast the functional characteristics of hmAbs with the potential for prophylaxis and treatment of diseases caused by SARS CoV, HeV and NiV.
METHODS: A review of relevant literature. RESULTS/
CONCLUSIONS: Structural, functional and biochemical analyses [corrected] have provided insights into the molecular mechanisms of receptor recognition and antibody neutralization, and suggested that these antibodies alone or in combination could fight the viruses' heterogeneity and mutability, which is a major problem in the development of effective therapeutic agents against viruses, including therapeutic antibodies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19216624      PMCID: PMC2705284          DOI: 10.1517/14712590902763755

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  117 in total

1.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

Authors:  Christian Drosten; Stephan Günther; Wolfgang Preiser; Sylvie van der Werf; Hans-Reinhard Brodt; Stephan Becker; Holger Rabenau; Marcus Panning; Larissa Kolesnikova; Ron A M Fouchier; Annemarie Berger; Ana-Maria Burguière; Jindrich Cinatl; Markus Eickmann; Nicolas Escriou; Klaus Grywna; Stefanie Kramme; Jean-Claude Manuguerra; Stefanie Müller; Volker Rickerts; Martin Stürmer; Simon Vieth; Hans-Dieter Klenk; Albert D M E Osterhaus; Herbert Schmitz; Hans Wilhelm Doerr
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

2.  Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies.

Authors:  Zhongyu Zhu; Antony S Dimitrov; Katharine N Bossart; Gary Crameri; Kimberly A Bishop; Vidita Choudhry; Bruce A Mungall; Yan-Ru Feng; Anil Choudhary; Mei-Yun Zhang; Yang Feng; Lin-Fa Wang; Xiaodong Xiao; Bryan T Eaton; Christopher C Broder; Dimiter S Dimitrov
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

3.  Lassa immune serum.

Authors:  A J Clayton
Journal:  Bull World Health Organ       Date:  1977       Impact factor: 9.408

4.  Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats.

Authors:  Susanna K P Lau; Patrick C Y Woo; Kenneth S M Li; Yi Huang; Hoi-Wah Tsoi; Beatrice H L Wong; Samson S Y Wong; Suet-Yi Leung; Kwok-Hung Chan; Kwok-Yung Yuen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-16       Impact factor: 11.205

5.  Phase I/II trial of HIV-1 hyperimmune globulin for the prevention of HIV-1 vertical transmission in Uganda.

Authors:  Laura A Guay; Philippa Musoke; David L Hom; Clemensia Nakabiito; Danstan Bagenda; Courtney V Fletcher; Lawrence H Marum; Mary Glenn Fowler; Lars G Falksveden; Britta Wahren; Peter Kataaha; Hans Wigzell; Francis A Mmiro; J Brooks Jackson
Journal:  AIDS       Date:  2002-07-05       Impact factor: 4.177

6.  Antiviral immunotherapy: a review of current status.

Authors:  J A DesJardin; D R Snydman
Journal:  BioDrugs       Date:  1998-06       Impact factor: 5.807

7.  Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2.

Authors:  Thomas A Bowden; A Radu Aricescu; Robert J C Gilbert; Jonathan M Grimes; E Yvonne Jones; David I Stuart
Journal:  Nat Struct Mol Biol       Date:  2008-05-18       Impact factor: 15.369

8.  Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus.

Authors:  Jody D Berry; Steven Jones; Michael A Drebot; Anton Andonov; Marta Sabara; Xin Y Yuan; Hana Weingartl; Lisa Fernando; Peter Marszal; Jason Gren; Brigitte Nicolas; Maya Andonova; Francesca Ranada; Michael J Gubbins; T Blake Ball; Paul Kitching; Yan Li; Amin Kabani; Frank Plummer
Journal:  J Virol Methods       Date:  2004-09-01       Impact factor: 2.014

9.  Immunogenicity of SARS inactivated vaccine in BALB/c mice.

Authors:  Sheng Xiong; Yi-Fei Wang; Mei-Ying Zhang; Xin-Jian Liu; Chuan-Hai Zhang; Shi-Sheng Liu; Chui-Wen Qian; Jiu-Xiang Li; Jia-Hai Lu; Zhuo-Yue Wan; Huan-Yin Zheng; Xin-Ge Yan; Min-Jie Meng; Jiang-lin Fan
Journal:  Immunol Lett       Date:  2004-09       Impact factor: 3.685

10.  The SARS-CoV S glycoprotein: expression and functional characterization.

Authors:  Xiaodong Xiao; Samitabh Chakraborti; Anthony S Dimitrov; Kosi Gramatikoff; Dimiter S Dimitrov
Journal:  Biochem Biophys Res Commun       Date:  2003-12-26       Impact factor: 3.575

View more
  29 in total

1.  Evaluation of two magnetic-bead-based viral nucleic acid purification kits and three real-time reverse transcription-PCR reagent systems in two TaqMan assays for equine arteritis virus detection in semen.

Authors:  Fabien Miszczak; Kathleen M Shuck; Zhengchun Lu; Yun Young Go; Jianqiang Zhang; Stephen Sells; Astrid Vabret; Stéphane Pronost; Guillaume Fortier; Peter J Timoney; Udeni B R Balasuriya
Journal:  J Clin Microbiol       Date:  2011-08-10       Impact factor: 5.948

2.  Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies.

Authors:  Tianlei Ying; Lanying Du; Tina W Ju; Ponraj Prabakaran; Candy C Y Lau; Lu Lu; Qi Liu; Lili Wang; Yang Feng; Yanping Wang; Bo-Jian Zheng; Kwok-Yung Yuen; Shibo Jiang; Dimiter S Dimitrov
Journal:  J Virol       Date:  2014-04-30       Impact factor: 5.103

3.  The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection.

Authors:  Elin S Gray; Maphuti C Madiga; Tandile Hermanus; Penny L Moore; Constantinos Kurt Wibmer; Nancy L Tumba; Lise Werner; Koleka Mlisana; Sengeziwe Sibeko; Carolyn Williamson; Salim S Abdool Karim; Lynn Morris
Journal:  J Virol       Date:  2011-03-09       Impact factor: 5.103

4.  Rhabdovirus-based vaccine platforms against henipaviruses.

Authors:  Drishya Kurup; Christoph Wirblich; Heinz Feldmann; Andrea Marzi; Matthias J Schnell
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

5.  Immune-Based Therapy for COVID-19.

Authors:  Abdolreza Esmaeilzadeh; Davood Jafari; Safa Tahmasebi; Reza Elahi; Elnaz Khosh
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 6.  Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections.

Authors:  Hilal Ahmad Parray; Shivangi Shukla; Reshma Perween; Ritika Khatri; Tripti Shrivastava; Vanshika Singh; Praveenkumar Murugavelu; Shubbir Ahmed; Sweety Samal; Chandresh Sharma; Subrata Sinha; Kalpana Luthra; Rajesh Kumar
Journal:  Appl Microbiol Biotechnol       Date:  2021-08-23       Impact factor: 5.560

7.  Identification and Development of Therapeutics for COVID-19.

Authors:  Halie M Rando; Nils Wellhausen; Soumita Ghosh; Alexandra J Lee; Anna Ada Dattoli; Fengling Hu; James Brian Byrd; Diane N Rafizadeh; Ronan Lordan; Yanjun Qi; Yuchen Sun; Christian Brueffer; Jeffrey M Field; Marouen Ben Guebila; Nafisa M Jadavji; Ashwin N Skelly; Bharath Ramsundar; Jinhui Wang; Rishi Raj Goel; YoSon Park; Simina M Boca; Anthony Gitter; Casey S Greene
Journal:  mSystems       Date:  2021-11-02       Impact factor: 6.496

8.  Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens.

Authors:  Xiaodong Xiao; Weizao Chen; Yang Feng; Zhongyu Zhu; Ponraj Prabakaran; Yanping Wang; Mei-Yun Zhang; Nancy S Longo; Dimiter S Dimitrov
Journal:  Biochem Biophys Res Commun       Date:  2009-09-11       Impact factor: 3.575

Review 9.  Monoclonal antibody-based therapies for microbial diseases.

Authors:  Carolyn Saylor; Ekaterina Dadachova; Arturo Casadevall
Journal:  Vaccine       Date:  2009-12-30       Impact factor: 3.641

Review 10.  Humoral immune mechanisms involved in protective and pathological immunity during COVID-19.

Authors:  Gunawan Widjaja; Abduladheem Turki Jalil; Heshu Sulaiman Rahman; Walid Kamal Abdelbasset; Dmitry O Bokov; Wanich Suksatan; Mahnaz Ghaebi; Faroogh Marofi; Jamshid Gholizadeh Navashenaq; Farhad Jadidi-Niaragh; Majid Ahmadi
Journal:  Hum Immunol       Date:  2021-07-01       Impact factor: 2.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.